A role for corticotropin-releasing factor in repeated cold stress-induced anxiety-like behavior during forced swimming and elevated plus-maze tests in mice

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 3, 2004, Pages 352-356

  Nishikawa, Hiroyuki ^a   Hata, Taeko ^a   Itoh, Eiji ^a   Funakami, Yoshinori ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Anxiety; Corticotropin releasing factor (CRF); Elevated plus maze test; Forced swimming test; Repeatedly cold stress; Specific alternation of rhythm in temperature (SART) stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; ALPHA HELICAL CORTICOTROPIN RELEASING HORMONE; ALPHA HELICAL CORTICOTROPIN-RELEASING HORMONE;

ADRENALECTOMY; ALPHA HELIX; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ANXIETY DISORDER; ARTICLE; COLD STRESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MAZE TEST; MOUSE; NONHUMAN; TEMPERATURE SENSITIVITY; ANIMAL; ANIMAL BEHAVIOR; COLD; COMPARATIVE STUDY; DRUG EFFECT; MENTAL STRESS; MOTOR ACTIVITY; MOUSE STRAIN; PSYCHOLOGICAL ASPECT; SWIMMING;

ADRENALECTOMY; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; COLD; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 16544368377     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.352     Document Type: Article

References (42)

1. Vale W., Spiess J., Rivier C., Rivier J., Science, 213, 1394-1397 (1981).
2. Owens M. J., Nemeroff C. B., Pharmacol. Rev., 43, 425-473 (1991).
3. Linthorst A. C., Flachskamm C., Hopkins S. J., Hoadley M. E., Labeur M. S., Holsboer F., Reul J. M., J. Neurosci., 17, 4448-4460 (1997).
4. Sutton R. E., Koob G. F., Le Moal M., Rivier J., Vale W., Nature (London), 297, 331-333 (1982).
5. Nemeroff C. B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C. D., Loosen P. T., Vale W., Science, 226, 1342-1344 (1984).
6. Holsboer F., Von Bardeleben U., Gerken A., Stalla G. K., Muller O. A., N. Engl. J. Med., 311, 1127 (1984).
7. Kita T., Hata T., Yoneda R., Okage T., Nippon Yakurigaku Zasshi, 71, 195-210 (1975).
8. Kita T., Hata T., Itoh E., Namimatsu A., Jpn. J. Psychosom. Med., 23, 61-68 (1983).
9. Uchida S., Takeyasu K., Noguchi Y., Yoshida H., Hata T., Kita T., Life Sci., 22, 2197-2203 (1978).
10. Kawabata A., Hata T., Br. J. Pharmacol., 119, 346-350 (1996).
11. Kawabata A., Hata T., Thromb. Res., 72, 321-331 (1993).
12. Hata T., Nishimura Y., Kita T., Kawabata A., Itoh E., Jpn. J. Pharmacol., 45, 365-372 (1987).
13. Hata T., Kita T., Itoh E., Namimatsu A., Nippon Yakurigaku Zasshi, 79, 487-492 (1982).
14. Hata T., Itoh E., Nishikawa H., Pharmacol. Biochem. Behav., 51, 849-853 (1995).
15. Hata T., Nishikawa H., Itoh E., Watanabe A., Jpn. J. Pharmacol., 79, 243-249 (1999).
16. Hata T., Nishikawa H., Itoh E., Funakami Y., Jpn. J. Pharmacol., 85, 189-196 (2001).
17. Porsolt R. D., Bertin A., Jalfre M., Arch. Int. Pharmacodyn. Ther., 229, 327-336 (1977).
18. Porsolt R. D., Le Pichon M., Jalfre M., Nature (London), 266, 730-732 (1977).
19. Betin C., DeFeudis F. V., Blavet N., Clostre F., Physiol. Behav., 28, 307-311 (1982).
20. Devoize J. L., Rigal F., Eschalier A., Trolese J. F., Renoux M., Psychopharmacology (Berl), 84, 71-75 (1984).
21. Nagatani T., Sugihara T., Kodaira R., Eur. J. Pharmacol., 97, 271-275 (1984).
22. Nagatani T., Yamamoto T., Sugihara T., Ueki S., Eur. J. Pharmacol., 142, 17-22 (1987).
23. Lister R. G., Psychopharmacology (Berl), 92, 180-185 (1987).
24. Brittain R. T., Handley S. L., J. Physiol., 192, 805-813 (1967).
25. Hata T., Kita T., Itoh E., Harada N., Jpn. J. Psychosom. Med., 24, 256-266 (1984).
26. Urani A., Roman F. J., Phan V. L., Su T. P., Maurice T., J. Pharmacol. Exp. Ther., 298, 1269-1279 (2001).
27. Hata T., Nishimura Y., Kita T., Itoh E., Kawabata A., Jpn. J. Pharmacol., 48, 479-490 (1988).
28. Nishimura Y., Hata T., Kawabata A., Itoh E., Kita T., Jpn. J. Pharmacol., 49, 111-117 (1989).
29. Reul J. M., Holsboer F., Curr. Opin. Pharmacol., 2, 23-33 (2002).
30. Chalmers D. T., Lovenberg T. W., Grigoriadis D. E., Behan D. P., De Souza E. B., Trends Pharmacol. Sci., 17, 166-172 (1996).
31. Reul J. M., Holsboer F., Curr. Opin. Pharmacol., 2, 23-33 (2002).
32. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J. M., Stalla G. K., Blanquet V., Steckler T., Holsboer F., Wurst W., Nat. Genet., 19, 162-166 (1998).
33. Okuyama S., Chaki S., Kawashima N., Suzuki Y., Ogawa S., Nakazato A., Kumagai T., Okubo T., Tomisawa K., J. Pharmacol. Exp. Ther., 289, 926-935 (1999).
34. Bale T. L., Contarino A., Smith G. W., Chan R., Gold L. H., Sawchenko P. E., Koob G. F., Vale W. W., Lee K. F., Nat. Genet., 24, 410-414 (2000).
35. Baldwin H. A., Rassnick S., Rivier J., Koob G. F., Britton K. T., Psychopharmacology, 103, 227-232 (1991).
36. Heinrichs S. C., Merlo P. E., Miczek K. A., Britton K. T., Koob G. F., Brain Res., 581, 190-197 (1992).
37. Menzaghi F., Howard R. L., Heinrichs S. C., Vale W., Rivier J., Koob G. F., J. Pharm. Exp. Ther., 267, 564-572 (1994).
38. Palkovits M., Prog. Brain Res., 72, 47-55 (1987).
39. Gass P., Reichardt H. M., Strekalova T., Henn F., Tronche F., Physiol. Behav., 73, 811-825 (2001).
40. Smythe J. W., Murphy D., Timothy C., Costall B., Pharmacol. Biochem. Behav., 56, 507-513 (1997).
41. De Kloet E. R., Vreugdenhil E., Oitzl M. S., Joels M., Endocr. Rev., 19, 269-301 (1998).
42. Brown E. S., Rush A. J., McEwen B. S., Neuropsychopharmacology, 21, 474-484 (1999).